News Release 

Microvascular disease anywhere in the body may be linked to higher risk of leg amputations

Circulation Journal Report

American Heart Association

DALLAS, July 8, 2019 -- Microvascular disease is independently associated with a higher risk of leg amputation compared to people without the disease, according to new research in the American Heart Association's journal Circulation.

The study, funded by the American Heart Association Strategically Focused Research Network in Vascular Disease and the U.S. Department of Veterans Affairs, examined amputation risk among people with microvascular disease or peripheral artery disease (PAD) or those who had both microvascular disease and PAD. Researchers used data from the Veterans Aging Cohort Study, which included more than 125,000 veterans who initially did not have amputations when the study began. Over an average of nine years, participants with:

microvascular disease had a 3.7-fold increased risk of lower limb amputation, and experienced 18% of all amputations during the study;

PAD had a 13.9-fold increased risk of lower limb amputation and suffered 22% of all amputations; microvascular disease and PAD had a 23-fold increase in the risk of lower limb amputation which accounted for 45% of all amputations.

PAD is a narrowing of the arteries away from the heart and is typically found in the legs. It causes cramping, pain or fatigue in the leg muscles while walking or climbing stairs. If left untreated, PAD can lead to gangrene and the need for amputation.

In microvascular disease, tiny vessels that carry blood to muscles and other tissues throughout the body no longer function properly. While the disease is commonly diagnosed in the eyes (retinopathy) or in the kidney (nephropathy), the authors believe those are markers of microvascular dysfunction throughout the body.

"This study advances the idea that microvascular disease is a system-wide disorder rather than only affecting one part of the body," said Joshua A. Beckman, M.D., lead author of the study and professor of medicine and director of Vascular Medicine at Vanderbilt University Medical Center in Nashville, Tennessee.

"PAD (in the legs) has long been considered a sign that a patient likely also has narrowed arteries leading to the heart or brain. If a patient has PAD, they have a higher risk of other cardiovascular diseases, such as heart attacks and strokes," Beckman said. "Our study suggests that microvascular disease in any part of the body, such as the eyes, kidneys or feet (neuropathy) may be linked to decreased blood vessel function in other parts of the body, putting patients at risk for potential lower-limb amputations."

Based on the findings, Beckman suggests patients with microvascular disease require close observation and care of their feet to detect sores or injuries early to promote healing and reduce amputations. "Patients with both microvascular disease and PAD have the highest risk of lower-limb amputation and need maximal medical therapies to reduce their risk," Beckman said.

###

Study co-authors are Meredith S. Duncan, M.A.; Scott M. Damrauer, M.D.; Quinn S. Wells, M.D.; Joey V. Barnett, Ph.D.; David H. Wasserman, Ph.D.; Roger J. Bedimo, M.D.; Adeel A. Butt, M.D.; Vincent C. Marconi, M.D.; Jason J. Sico, M.D.; Hilary A. Tindle, M.D.; Marc P. Bonaca, M.D.; Aaron W. Aday, M.D.; and Matthew S. Freiberg, M.D. Author disclosures are on the manuscript.

Additional Resources:

Available multimedia is on right column of release link - https://newsroom.heart.org/news/microvascular-disease-anywhere-in-the-body-may-be-linked-to-higher-risk-of-leg-amputations?preview=b9da7aa7b6ada3b9411d9c25eb6c7f2e

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.

About the American Heart Association

The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies, and share lifesaving resources and information. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.